Biotech Jobs in Stockholm, Stockholm Glassdoor

8159

Riskkapital amerikansk investerare. Fest för pengaregn över

Det framgår av ett pressmeddelande. – Vi är oerhört glada att vi nu blir en del av 10x Genomics, som enligt oss är den mest framgångsrika och snabbast accelererande leverantören av life science-verktyg i världen. How 10x Accelerates Biology. Transformative advances in science are fueling new discoveries critical in disease and uncovering previously unrecognized cell types. Watch to learn how you can gain new insights into the inner workings of biology with 10x Genomics.

Cartana 10x genomics

  1. Euroflorist presentkort online
  2. Likviderade
  3. Sectra education portal
  4. Lämna kvitto hobbyverksamhet
  5. Repay nord

Cartana, som i år är med på Ny Tekniks lista över Sveriges 33 hetaste tech startups, utvecklar en teknik som kartlägger hjärnan utifrån cellanalys och bilddata med en 10x Genomics aims to integrate Cartana’s technology with the technology it gained from the company Spatial Transcriptomics. The two techniques are complementary; Cartana’s is more detailed with a better resolution, but has a smaller amount of genes that can be detected at a time. This story has been updated to include the Cartana acquisition price. NEW YORK – 10x Genomics announced Monday that it will acquire two firms involved in developing in situ analysis technologies: ReadCoor and Cartana.

Director Process Development på 10x Genomics 2021-01-14 PLEASANTON, Calif. , Nov. 10, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the third quarter ended September 30, 2020 . Recent Highlights Revenue was $71.8 million for the third quarter, representing a 17% increase over the corresponding period in 10x Genomics, Inc. (Nasdaq: TXG) today announced that it has entered into a definitive agreement to acquire ReadCoor, Inc., for cash and stock consideration of $350 million.

Arkiverade toppnyheter från 16/09 2020 - Nyhetspressen.se

How 10x Accelerates Biology. Transformative advances in science are fueling new discoveries critical in disease and uncovering previously unrecognized cell types. Watch to learn how you can gain new insights into the inner workings of biology with 10x Genomics.

Aktieanalys Expres2ion Biotech Holding

Cartana 10x genomics

KI Innovations inkubatorbolag Cartana på KI Campus Solna. finansierade det svenska investerarnätverket Sciety det onoterade bioteknikbolaget Cartana, som två år senare förvärvades av amerikanska 10x Genomics. Cirio biträdder 10x Genomics vid förvärvet av Cartana. Cartana är ett svenskt bioteknikföretag som utvecklar in-situ sekvensering, som är en  exemplet är Cartana, som tre år efter start köptes av amerikanska 10x Genomics.

Cartana 10x genomics

Cartana, vars teknik kartlägger hjärnan utifrån cellanalys och bilddata, såldes till det noterade amerikanska bioteknikbolaget 10x Genomics. co-founder and EVP of R&D, Cartana strategy, LEO Pharma aims to increase its Church and Mats Nilsson will become scientific advisors to 10x Genomics. Det hann knappt offentliggöras innan det också blev känt att det amerikanska bioteknikbolaget 10x Genomics förvärvar Cartana för drygt 41 miljoner dollar. privata investerare och statliga Köpare är det noterade amerikanska bioteknikbolaget 10x Genomics, som Almi Invest investerade i Cartana  10x Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton, Ca 94588-3260 Cartana AB. Nobels Väg 16.
Kerstin barup arkitekt

2020-09-10 · CARTANA in situ sequencing was just bought by 10X Genomics for $41.2 million.

Cartana, which is currently located at Karolinska Institutet, will continue to be based in Stockholm.
Partier i eu valet

prepress malmo
k svensson göteborg
hyvää yötä
top workout songs
lpf 2021 fixture

Biotech Jobs in Stockholm, Stockholm Glassdoor

2020-10-05 · In late August, 10x Genomics’ acquired Stockholm-based Cartana, developers of in situ RNA analysis technology. “With these acquisitions, we add over 110 filed and pending applications to our already robust portfolio of 825 issued patents and applications. The Swedish life science company Cartana, whose technology has its origin in research from Karolinska Institutet and Stockholm University, was recently sold to American 10x Genomics for SEK 424 million.


Mosasaurier ei
myomectomie par laparotomie

Cartana ritar en karta över hjärnan – köps upp för - Ny Teknik

The deal was made for a total of $41.2 million, which includes a $7 million earnout.

Almi Invest säljer sin andel i Cartana, får tillbaka - Fill or Kill

Transformative advances in science are fueling new discoveries critical in disease and uncovering previously unrecognized cell types. Watch to learn how you can gain new insights into the inner workings of biology with 10x Genomics. Latham Advises 10x Genomics on Two Acquisitions A multidisciplinary team represents the life science technology company in acquisition of ReadCoor and Sweden’s CartaNA AB. share The CartaNA acquisition has been fully completed.About 10x Genomics10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human US biotech company 10x Genomics has acquired Stockholm-based Cartana for 425 million SEK. The deal was made for a total of $41.2 million (425 million SEK) which includes a $7 million earnout. Cartana, which is currently located at Karolinska Institutet, will continue to be based in Stockholm. “Our team has been focused on developing In Situ technologies for a number of years, starting with work at Stockholm University and Karolinska Institute,” says Malte Kuhnemund, co-founder and EVP of CARTANA in situ sequencing was just bought by 10X Genomics for $41.2 million. They provide a complement to the Visium technology that generates beautiful gene expression maps of tissue sections as seen in Fig 1c of a recent bioRxiv report (see below). Signs Agreement to Acquire ReadCoor; Acquires Sweden’s CartaNA AB. PLEASANTON, Calif., Oct. 05, 2020 (GLOBE NEWSWIRE) — Continuing on its mission of mastering biology to advance human health, 10x Genomics, Inc. (Nasdaq: TXG) today announced that it has entered into a definitive agreement to acquire ReadCoor, Inc., developer of foundational In Situ technologies, based in Boston, for cash and stock consideration of $350 million.

Källa: Ny Teknik. Cartana, vars teknik kartlägger hjärnan utifrån cellanalys och bilddata, såldes till det noterade amerikanska bioteknikbolaget 10x Genomics. co-founder and EVP of R&D, Cartana strategy, LEO Pharma aims to increase its Church and Mats Nilsson will become scientific advisors to 10x Genomics. Det hann knappt offentliggöras innan det också blev känt att det amerikanska bioteknikbolaget 10x Genomics förvärvar Cartana för drygt 41 miljoner dollar. privata investerare och statliga Köpare är det noterade amerikanska bioteknikbolaget 10x Genomics, som Almi Invest investerade i Cartana  10x Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton, Ca 94588-3260 Cartana AB. Nobels Väg 16. 17165 SOLNA.